Results 91 to 100 of about 5,163 (181)

Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes Study

Drugs - Real World Outcomes
Background and Objective Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia results in substantial morbidity and mortality. As current treatments often lead to unsatisfactory outcomes, evidence guiding alternative treatment options is needed ...
Jennifer Hammond, Michael Benigno, Nataly Bleibdrey, Wajeeha Ansari, Jennifer L. Nguyen   +4 more
doaj   +1 more source

Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study

Infection and Drug Resistance
Tristan Ferry,1 Charalambos Gogos,2 Alex Soriano,3 Francesco Blasi,4,5 Wajeeha Ansari,6 Michal Kantecki,7 Bernd Schweikert,8 Gustavo Luna,9 Matteo Bassetti10 1Infectious Diseases Department, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France ...
Ferry T, Gogos C, Soriano A, Blasi F, Ansari W, Kantecki M, Schweikert B, Luna G, Bassetti M   +8 more
doaj  

In Vitro Activity Of Ceftaroline And Comparators Against Staphylococcus aureus Isolates: Results From 6 Years Of The ATLAS Program (2012 To 2017)

Infection and Drug Resistance, 2019
Zhijie Zhang,1 Meng Chen,2 Ying Yu,3 Beini Liu,3 Yong Liu1 1Department of Clinical Laboratory, Shengjing Hospital, Shenyang, People’s Republic of China; 2Department of Rheumatology, Affiliated Hospital of Hebei University, Baoding, People’s ...
Zhang Z, Chen M, Yu Y, Liu B, Liu Y
doaj  

Ceftaroline for Central Nervous System Infections: Case Report of a Young Infant, and Scoping Review.

BACKGROUND: Managing health care acquired and device-associated intracranial infections in young children can be challenging given adverse antibiotic side effects and difficulties in achieving adequate central nervous system (CNS) antibiotic ...
Sileo, Nicole, Vuppula, Sharon, Lerma, Sergio, Nguyen, Kevin, Nielsen, Marisa, Sosa Soto, Giordano, Campbell, Jeffrey I, Urbach, Haley, Holsapple, James, Heiderich, Amy   +9 more
core   +1 more source

<i>In vitro</i> activity of ceftaroline against clinical isolates of Gram-positive bacteria in paediatric patients: ATLAS programme 2018-2023. [PDF]

JAC Antimicrob Resist
Kiratisin P, Kuraieva A, Utt E, Esposito S.   +3 more
europepmc   +1 more source

Assessment of Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates to Ceftaroline and Other Antistaphylococcal Agents. [PDF]

Cureus
Gupta R, Agarwal S, Jafar H, Prakash V.
europepmc   +1 more source

Ceftaroline pharmacokinetics on ECMO, a pediatric case report. [PDF]

Int J Antimicrob Agents
Pavia K, Bellamy A, Burns A, Scott A, Poweleit EA.   +4 more
europepmc   +1 more source

Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

, 2017
Novel therapies for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) are needed in the setting of reduced antibiotic susceptibilities and therapeutic failure.
Davis, Susan L, Casapao, Anthony M, Klinker, Kenneth P, Claeys, Kimberly C, Rybak, Michael J, Trinh, Trang D, Sabagha, Noor, Lagnf, Abdalhamid M, Zasowski, Evan J   +8 more
core  

Ceftaroline and ceftobiprole monotherapy for the treatment of Staphylococcus aureus infections: a systematic review and Bayesian meta-analysis. [PDF]

J Antimicrob Chemother
Rando E, Magrini E, Sangiorgi F, Salvati F, Catania F, Chiuchiarelli M, Matteini E, Fantoni M, Torti C, López-Cortés LE, Rodríguez-Baño J, Murri R.   +11 more
europepmc   +1 more source

Impact of early vs delayed initiation of dual antimicrobial salvage therapy on clinical outcomes in MRSA bacteremia. [PDF]

Microbiol Spectr
Sanderford V, Tabliago NRA, Alnami S, Spencer S, Colven R, Rey Alvira-Arill G, Gruss Z, Ehrenberger L, Hamby A, Kosharek A, Thacker S, Mediwala Hornback K, Morrisette T, Lueking R.   +13 more
europepmc   +1 more source